Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

So-called “less-lethal” weapons like those that have been used against demonstrators in Los Angeles can cause severe, lasting ...

NB.1.8.1 has mutations that could increase the virus’s transmissibility and decrease the efficacy of certain neutralizing ...

Eli Lilly & Co. will only work with telehealth firms that agree to stop selling copycat versions of weight-loss drugs, diminishing the likelihood of a partnership with one most visible players in the ...

Hims & Hers Health Inc (NYSE:HIMS) stock fell 3.8% Tuesday after Eli Lilly and Company (NYSE:LLY) indicated it would not partner with telehealth firms selling copycat versions of weight-loss drugs, ...

Health-care companies rose amid sales growth optimism. Drug-store chain CVS Health said it has seen complaints of strong push back from patients on its pharmacy-benefit manager's move to favor Novo ...

TheStreet. Even the Hamburglar didn’t see this one coming. Excessive weight has been a persistent problem in America, where at least one in five adults in each U.S. state is living with obesity, ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as ...

Scientists know the stomach talks to the brain, but two new studies from Rutgers Health researchers suggest the conversation ...